Monthly Archives: Agosto 2021
COVID-19: Study Warns Lung Damage Continues In The Recovered
A new study shows that the persistent breathing issues that plague some COVID-19 survivors, known as "long COVID," may be due to microscopic processes that continue to damage lungs even after the acute infection...
Delta variant doubles risk of COVID-19 hospitalisation
The B.1.617.2 variant also known as the Delta variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. It is suspected that the delta variant...
SARS-CoV-2 altera l’RNA dell’ospite umano per migliorare l’attività virale
I risultati dello studio dei ricercatori dell'Agenzia per la scienza, la tecnologia e la ricerca di Singapore (A*STAR), la Duke-NUS Medical School di Singapore e la Yong Loo Lin School of Medicine della National...
Postponing retirement is protective against cognitive decline
Postponing retirement is protective against cognitive decline. The beneficial effect is related to a slowed rate of cognitive decline rather than a boost in cognitive function.
That is what a recent study by MPIDR...
A cancer drug repurposed to treat malaria has been shown to be nearly 100%...
A cancer drug repurposed to treat malaria has been shown to be nearly 100% effective in helping defeat the disease in just three days, according to the results of a Phase 2 clinical trial.
The...
SARS-CoV-2 Alters Human Host RNA To Improve Viral Fitness
Study findings by researchers from the Agency for Science, Technology and Research-Singapore ( (A*STAR), Duke-NUS Medical School-Singapore and the Yong Loo Lin School of Medicine at the National University of Singapore have alarmingly found that...
Maternal voice induces an increase of oxytocin in premature babies reducing pain
A baby born prematurely often has to be separated from its parents and placed in an incubator in intensive care. For several weeks, he or she will undergo routine medical procedures that can be...
L’iniezione di BNT162b2 COVID-19 di Pfizer aumenta il rischio di miocardite di tre volte
In modo allarmante un nuovo studio condotto da ricercatori del Clalit Research Institute-Israele, Ben-Gurion University of the Negev, Be'er Sheva-Israel, Harvard Medical School-USA e Boston Children's Hospital-USA ha scoperto che la somministrazione del Pfizer-BioNTech BNT162b2...
La variante Delta AY12 del COVID-19 si sta diffondendo rapidamente in India e l’AY3...
L'INSACOG o il consorzio India SARS-CoV-2 Genome riportano la prevalenza della sottolinea variante Delta AY12 in India che è stata collegata a un'ondata di COVID-19 in Israele.
È interessante notare che la variante Delta (B.1.617.2)...
COVID-19 Delta Variant A.Y.12 Is Fast Spreading In India and A.Y.3 Is Able To...
INSACOG or the India SARS-CoV-2 Genome consortium reports prevalence of the Delta variant sub-lineage A.Y.12 in India that has been linked to a COVID-19 surge in Israel.
Interestingly the Delta variant (B.1.617.2) has ‘birthed’ several...
Pfizer’s BNT162b2 COVID-19 Shot Increases Risk of Myocarditis By Threefold
Alarmingly a new study by researchers from Clalit Research Institute-Israel, Ben-Gurion University of the Negev, Be’er Sheva-Israel, Harvard Medical School-USA and Boston Children’s Hospital-USA has found that the Pfizer- BioNTech BNT162b2 shot was associated...
New South African SARS-CoV-2 variant called C.1.2 could change the course of the pandemic...
outh African researchers from the National Institute for Communicable Diseases (NICD), University of the Witwatersrand, University of Cape Town, University of Pretoria, University of KwaZulu-Natal and the Charlotte Maxeke Johannesburg Academic Hospital have discovered...
French Study Claims That ADE Is Occurring In Delta Variant Infections
A new study by French researchers from Aix-Marseille Université has alarmingly found that ADE or antibody dependent enhancement is indeed occurring in infections with the SARS-CoV-2 Delta variant.
The study findings were peer reviewed and...
Fluvoxamina: un antidepressivo emergente come farmaco leader per il trattamento del COVID-19
Farmaci COVID-19 : la fluvoxamina, un farmaco antidepressivo poco costoso, sta ora emergendo come potenziale candidato da riproporre per il trattamento del COVID-19.
Ci sono speculazioni che il Canada potrebbe essere il primo paese ad approvare...
Uno studio francese afferma che l’ADE si verifica nelle infezioni della variante Delta
Un nuovo studio condotto da ricercatori francesi dell'Università di Aix-Marseille ha scoperto in modo allarmante che l'ADE o il potenziamento dipendente da anticorpi si sta effettivamente verificando nelle infezioni con la variante SARS-CoV-2 Delta.
I...
